|
000
| 02535nam 2200481zi 4500 |
|---|
| 001 | 9.919794 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20230517120919 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 230206t20232023onca o f000 0 eng d |
|---|
| 020 | |a9780660474397 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 045 | |ay2y2 |
|---|
| 086 | 1 |aH14-365/2-2023E-PDF |
|---|
| 245 | 00|aDementia public education phase 2 - creative concept testing prevention : |bfinal report / |cprepared for the Public Health Agency of Canada. |
|---|
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2023. |
|---|
| 264 | 4|c©2023 |
|---|
| 300 | |a1 online resource (37 pages) : |bcolour illustrations + |eexecutive summary (3 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Sensibilisation du public à la démence (deuxième phase) - évaluation de concepts pour la prévention : rapport final. |
|---|
| 500 | |a"Supplier Name: Phoenix SPI." |
|---|
| 500 | |a"Contract Number: HT372-213363/001/CY." |
|---|
| 500 | |a"Registration Number: POR #017-21." |
|---|
| 500 | |a"February 2023." |
|---|
| 500 | |a"Prepared for Health Canada." |
|---|
| 650 | 0|aDementia|zCanada|xPublic opinion. |
|---|
| 650 | 0|aDementia|xRisk factors|zCanada|xPublic opinion. |
|---|
| 650 | 0|aDementia|zCanada|xPrevention|xPublic opinion. |
|---|
| 650 | 0|aGovernment advertising|zCanada|xPublic opinion. |
|---|
| 650 | 0|aAdvertising campaigns|zCanada|xPublic opinion. |
|---|
| 650 | 0|aPublic opinion|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 710 | 2 |aPhoenix Strategic Perspectives Inc., |econsultant. |
|---|
| 775 | 08|tSensibilisation du public à la démence (deuxième phase) - évaluation de concepts pour la prévention : |w(CaOODSP)9.919795 |
|---|
| 856 | 40|qPDF|s889 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/H14-365-2-2023-eng.pdf|z(final report) |
|---|
| 856 | 40|qPDF|s227 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/H14-365-2-2023-1-eng.pdf|z(executive summary) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/017-21-e/POR017-21-report.html|z(final report) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/017-21-e/summary/POR017-21-summary.html|z(executive summary) |
|---|